GPP
Great Point Partners Portfolio holdings
AUM
$154M
This Quarter Return
-3.85%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$219M
AUM Growth
+$219M
(+22%)
Cap. Flow
+$50M
Cap. Flow
% of AUM
22.81%
Top 10 Holdings %
Top 10 Hldgs %
58.14%
Holding
45
New
10
Increased
15
Reduced
9
Closed
7
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$13.2M |
| 2 |
THOR
THORATEC CORPORATION
THOR
|
$12.6M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$10.6M |
| 4 |
ARDM
Aradigm Corp Common Stock
ARDM
|
$8.92M |
| 5 |
Achieve Life Sciences
ACHV
|
$7.88M |
Top Sells
| 1 |
FURX
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
|
$17.9M |
| 2 |
Cassava Sciences
SAVA
|
$3.41M |
| 3 |
Cytokinetics
CYTK
|
$2.99M |
| 4 |
NSPH
NANOSPHERE INC. COM NEW
NSPH
|
$2.75M |
| 5 |
Protalix BioTherapeutics
PLX
|
$2.72M |
Sector Composition
| 1 | Healthcare | 76.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Neurocrine Biosciences
NBIX
$13.8B
| $22.4M | 9.98% | 1,512,103 +892,103 | +144% | +$13.2M |
|
|
HPTX
2
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| $17.2M | 7.64% | 657,984 +164,233 | +33% | +$4.29M |
|
|
DSCI
3
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $13.3M | 5.9% | 1,148,292 +223,292 | +24% | +$2.58M |
|
|
THOR
4
DELISTED
THORATEC CORPORATION
THOR
| $12.6M | 5.58% | +360,000 | New | +$12.6M |
|
|
INFI
5
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $12.2M | 5.43% | 958,600 +458,200 | +92% | +$5.84M |
|
6
Orthofix Medical
OFIX
$592M
| $10.9M | 4.85% | 300,700 +50,700 | +20% | +$1.84M |
|
|
ISEE
7
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $10.6M | 4.71% | +250,100 | New | +$10.6M |
|
|
8
Cassava Sciences
SAVA
$110M
| $9.74M | 4.33% | 1,694,256 -593,023 | -26% | -$3.41M |
|
|
ALIM
9
DELISTED
Alimera Sciences, Inc.
ALIM
| $9.63M | 4.28% | 1,610,316 +110,316 | +7% | +$660K |
|
|
ARDM
10
DELISTED
Aradigm Corp Common Stock
ARDM
| $8.92M | 3.97% | +1,008,062 | New | +$8.92M |
|
11
Tenax Therapeutics
TENX
$27.3M
| $8.63M | 3.84% | 2,115,497 +115,497 | +6% | +$471K |
|
12
Veracyte
VCYT
$2.39B
| $7.9M | 3.51% | 461,210 +150,962 | +49% | +$2.58M |
|
|
13
Achieve Life Sciences
ACHV
$152M
| $7.88M | 3.5% | +2,111,590 | New | +$7.88M |
|
|
AMBI
14
DELISTED
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
| $7.28M | 3.24% | 1,053,895 +334,634 | +47% | +$2.31M |
|
15
Arcturus Therapeutics
ARCT
$462M
| $5.76M | 2.56% | 332,908 +39,298 | +13% | +$680K |
|
|
ANTH
16
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $5.09M | 2.26% | 1,500,000 +130,763 | +10% | +$443K |
|
|
AVEO
17
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $4.26M | 1.89% | 2,325,000 -541,483 | -19% | -$991K |
|
|
SCTL
18
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $4.17M | 1.86% | 520,776 -59,224 | -10% | -$474K |
|
|
VOLC
19
DELISTED
VOLCANO CORPORATION COM STK
VOLC
| $4.1M | 1.82% | 232,645 -67,355 | -22% | -$1.19M |
|
|
SPHS
20
DELISTED
Sophiris Bio, Inc.
SPHS
| $3.55M | 1.58% | 1,585,500 +85,500 | +6% | +$191K |
|
21
Karyopharm Therapeutics
KPTI
$61.7M
| $3.49M | 1.55% | +75,000 | New | +$3.49M |
|
|
TVRD
22
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $3.41M | 1.52% | 200,219 +22,154 | +12% | +$377K |
|
|
CUTR
23
DELISTED
Cutera, Inc.
CUTR
| $3.16M | 1.4% | +303,713 | New | +$3.16M |
|
|
ELGX
24
DELISTED
Endologix Inc
ELGX
| $2.94M | 1.31% | +193,282 | New | +$2.94M |
|
|
CASC
25
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $2.57M | 1.14% | 791,800 -200,000 | -20% | -$648K |
|